The kinetics of peptide binding to HLA-A2 and the conformation of the peptide-A2 complex can be determined by amino acid side chains on the floor of the peptide binding groove

N. Shimojo, R. W. Anderson, David Mattson, R. V. Turner, J. E. Collgan, W. E. Biddison

Research output: Contribution to journalArticle

25 Citations (Scopus)

Abstract

The ability of amino acid side chains in the floor of the peptide binding groove of HLA-A2 to affect the presentation of a viral peptide to peptide-speclfic cytotoxic T lymphocytes (CTL) has been examined. HLA-A2 molecules with naturally occurring single amino acid substitutions of Phe to Tyr at position 9 (HLA-A2.4a, Tyr9) and Tyr to Cys at position 99 (HLA-A2.4b, Cys99) and a site directed mutant with a Val to Leu substitution at position 95 (Leu95) were examined for their ability to present the Influenza virus matrix M1 55-73 peptide and several sequence variants of the M1 peptide to a panel of 36 M1 55-73-speclfic HLA-A2.1-restricted CTL lines. The Leu95 molecule demonstrated enhanced kinetics of M1 peptide presentation and the ability to be sensitized by lower concentrations of the M1 peptide than the A2.1 molecule. The Tyr9 and Cys99 molecules exposed to M1 peptide were not recognized by 33 out of 36 CTL lines. The Tyr9 and Cys99 HLA-A2 molecules could bind the M1 55-73 peptide because at least one CTL line was found that could recognize each of these molecules that were exposed to the M1 peptide. CTL recognition patterns of variant M1 peptides presented by the Tyr9 molecule demonstrated that the amino acid at position 9 can be a critical determinant of the conformation of the peptide-A2 complex, and indicated that a particular peptide can bind in the HLA-A2 peptide binding groove In more than one conformation. These results demonstrate that amino acid side chains in the floor of the peptide binding groove can have a major functional role in determining the formation and conformation of the peptide-A2 complex that is recognized by peptide-speclfic CTL.

Original languageEnglish (US)
Pages (from-to)193-200
Number of pages8
JournalInternational Immunology
Volume2
Issue number3
DOIs
StatePublished - Mar 1990
Externally publishedYes

Fingerprint

HLA-A2 Antigen
Conformation
varespladib methyl
Peptides
Conformations
Amino Acids
Amino acids
Kinetics
T Lymphocytes
T-cells
Cytotoxic T-Lymphocytes
Molecules
Lymphocytes
Substitution
Line
Substitution reactions
Influenza

Keywords

  • Class I antigen presentation
  • Cytotoxic T lymphocytes
  • Mutant HLA-A2
  • Peptide binding groove
  • Viral antigen recognition

ASJC Scopus subject areas

  • Statistics, Probability and Uncertainty
  • Applied Mathematics
  • Public Health, Environmental and Occupational Health
  • Neuropsychology and Physiological Psychology
  • Transplantation
  • Immunology

Cite this

The kinetics of peptide binding to HLA-A2 and the conformation of the peptide-A2 complex can be determined by amino acid side chains on the floor of the peptide binding groove. / Shimojo, N.; Anderson, R. W.; Mattson, David; Turner, R. V.; Collgan, J. E.; Biddison, W. E.

In: International Immunology, Vol. 2, No. 3, 03.1990, p. 193-200.

Research output: Contribution to journalArticle

@article{164139ec90d14843b4d7cb85abf02099,
title = "The kinetics of peptide binding to HLA-A2 and the conformation of the peptide-A2 complex can be determined by amino acid side chains on the floor of the peptide binding groove",
abstract = "The ability of amino acid side chains in the floor of the peptide binding groove of HLA-A2 to affect the presentation of a viral peptide to peptide-speclfic cytotoxic T lymphocytes (CTL) has been examined. HLA-A2 molecules with naturally occurring single amino acid substitutions of Phe to Tyr at position 9 (HLA-A2.4a, Tyr9) and Tyr to Cys at position 99 (HLA-A2.4b, Cys99) and a site directed mutant with a Val to Leu substitution at position 95 (Leu95) were examined for their ability to present the Influenza virus matrix M1 55-73 peptide and several sequence variants of the M1 peptide to a panel of 36 M1 55-73-speclfic HLA-A2.1-restricted CTL lines. The Leu95 molecule demonstrated enhanced kinetics of M1 peptide presentation and the ability to be sensitized by lower concentrations of the M1 peptide than the A2.1 molecule. The Tyr9 and Cys99 molecules exposed to M1 peptide were not recognized by 33 out of 36 CTL lines. The Tyr9 and Cys99 HLA-A2 molecules could bind the M1 55-73 peptide because at least one CTL line was found that could recognize each of these molecules that were exposed to the M1 peptide. CTL recognition patterns of variant M1 peptides presented by the Tyr9 molecule demonstrated that the amino acid at position 9 can be a critical determinant of the conformation of the peptide-A2 complex, and indicated that a particular peptide can bind in the HLA-A2 peptide binding groove In more than one conformation. These results demonstrate that amino acid side chains in the floor of the peptide binding groove can have a major functional role in determining the formation and conformation of the peptide-A2 complex that is recognized by peptide-speclfic CTL.",
keywords = "Class I antigen presentation, Cytotoxic T lymphocytes, Mutant HLA-A2, Peptide binding groove, Viral antigen recognition",
author = "N. Shimojo and Anderson, {R. W.} and David Mattson and Turner, {R. V.} and Collgan, {J. E.} and Biddison, {W. E.}",
year = "1990",
month = "3",
doi = "10.1093/intimm/2.3.193",
language = "English (US)",
volume = "2",
pages = "193--200",
journal = "International Immunology",
issn = "0953-8178",
publisher = "Oxford University Press",
number = "3",

}

TY - JOUR

T1 - The kinetics of peptide binding to HLA-A2 and the conformation of the peptide-A2 complex can be determined by amino acid side chains on the floor of the peptide binding groove

AU - Shimojo, N.

AU - Anderson, R. W.

AU - Mattson, David

AU - Turner, R. V.

AU - Collgan, J. E.

AU - Biddison, W. E.

PY - 1990/3

Y1 - 1990/3

N2 - The ability of amino acid side chains in the floor of the peptide binding groove of HLA-A2 to affect the presentation of a viral peptide to peptide-speclfic cytotoxic T lymphocytes (CTL) has been examined. HLA-A2 molecules with naturally occurring single amino acid substitutions of Phe to Tyr at position 9 (HLA-A2.4a, Tyr9) and Tyr to Cys at position 99 (HLA-A2.4b, Cys99) and a site directed mutant with a Val to Leu substitution at position 95 (Leu95) were examined for their ability to present the Influenza virus matrix M1 55-73 peptide and several sequence variants of the M1 peptide to a panel of 36 M1 55-73-speclfic HLA-A2.1-restricted CTL lines. The Leu95 molecule demonstrated enhanced kinetics of M1 peptide presentation and the ability to be sensitized by lower concentrations of the M1 peptide than the A2.1 molecule. The Tyr9 and Cys99 molecules exposed to M1 peptide were not recognized by 33 out of 36 CTL lines. The Tyr9 and Cys99 HLA-A2 molecules could bind the M1 55-73 peptide because at least one CTL line was found that could recognize each of these molecules that were exposed to the M1 peptide. CTL recognition patterns of variant M1 peptides presented by the Tyr9 molecule demonstrated that the amino acid at position 9 can be a critical determinant of the conformation of the peptide-A2 complex, and indicated that a particular peptide can bind in the HLA-A2 peptide binding groove In more than one conformation. These results demonstrate that amino acid side chains in the floor of the peptide binding groove can have a major functional role in determining the formation and conformation of the peptide-A2 complex that is recognized by peptide-speclfic CTL.

AB - The ability of amino acid side chains in the floor of the peptide binding groove of HLA-A2 to affect the presentation of a viral peptide to peptide-speclfic cytotoxic T lymphocytes (CTL) has been examined. HLA-A2 molecules with naturally occurring single amino acid substitutions of Phe to Tyr at position 9 (HLA-A2.4a, Tyr9) and Tyr to Cys at position 99 (HLA-A2.4b, Cys99) and a site directed mutant with a Val to Leu substitution at position 95 (Leu95) were examined for their ability to present the Influenza virus matrix M1 55-73 peptide and several sequence variants of the M1 peptide to a panel of 36 M1 55-73-speclfic HLA-A2.1-restricted CTL lines. The Leu95 molecule demonstrated enhanced kinetics of M1 peptide presentation and the ability to be sensitized by lower concentrations of the M1 peptide than the A2.1 molecule. The Tyr9 and Cys99 molecules exposed to M1 peptide were not recognized by 33 out of 36 CTL lines. The Tyr9 and Cys99 HLA-A2 molecules could bind the M1 55-73 peptide because at least one CTL line was found that could recognize each of these molecules that were exposed to the M1 peptide. CTL recognition patterns of variant M1 peptides presented by the Tyr9 molecule demonstrated that the amino acid at position 9 can be a critical determinant of the conformation of the peptide-A2 complex, and indicated that a particular peptide can bind in the HLA-A2 peptide binding groove In more than one conformation. These results demonstrate that amino acid side chains in the floor of the peptide binding groove can have a major functional role in determining the formation and conformation of the peptide-A2 complex that is recognized by peptide-speclfic CTL.

KW - Class I antigen presentation

KW - Cytotoxic T lymphocytes

KW - Mutant HLA-A2

KW - Peptide binding groove

KW - Viral antigen recognition

UR - http://www.scopus.com/inward/record.url?scp=0025317586&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0025317586&partnerID=8YFLogxK

U2 - 10.1093/intimm/2.3.193

DO - 10.1093/intimm/2.3.193

M3 - Article

C2 - 2088485

AN - SCOPUS:0025317586

VL - 2

SP - 193

EP - 200

JO - International Immunology

JF - International Immunology

SN - 0953-8178

IS - 3

ER -